VHL and ovarian cancer: Ginsenoside Rg3 has also been shown to increase the expression of tumor suppressor von Hippel-Lindau (VHL) gene in ovarian cancer cells via suppressing DNMT3A expression and thus downregulating the DNA methylation level of the VHL promoter (Wang et al., 2021).